Center for Clinical Studies, LTD. LLP
Center for Clinical Studies, LTD. LLP
Webster, Texas, United States3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis. | Moderate to Severe Genital Psoriasis | Active, not recruiting | Phase 3 | 2026-09-01 | NCT06611163 | |
| A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster. | Arterial Occlusive Diseases, DNA Virus Infections, Herpesviridae infectious disease, Infections, Leukoencephalopathies, Varicella Zoster Virus Infection, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, herpes zoster, intracranial arterial disease, intracranial arteriosclerosis, nervous system disorder, psychiatric disorder, vascular dementia, vascular disorder, viral infectious disease | Recruiting | Not stated | 2025-12-11 | NCT06903078 | |
| A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma | nodular basal cell carcinoma | Recruiting | Phase 1 / Phase 2 | 2021-12-15 | NCT05157763 |